Key Conference Participation in September 2026

Summary by AI BETAClose X

Poolbeg Pharma plc will participate in several key scientific and investor conferences throughout September 2026, presenting its lead asset POLB 001 and discussing its AI in drug development initiatives. The company's CEO and CFO will present at the 28th Annual H.C. Wainwright Global Investment Conference in New York, while other presentations will cover topics such as AI in healthcare at the All-Ireland Clinical AI Congress, partnering opportunities at the Investor Summit in London, and the potential of POLB 001 at the International Myeloma Society Annual Meeting in Glasgow. The Executive Chair will also present at BIOShanghai Week in China.

Disclaimer*

UK 100

Latest directors dealings